DVAX / Dynavax Technologies Corporation (DVAX) CEO Ryan Spencer on Q4 2021 Results - Earnings Call Transcript

Start Time: 16:30 January 1, 0000 4:59 PM ET Dynavax Technologies Corporation (NASDAQ:DVAX ) Q3 2023 Earnings Conference Call November 02, 2023, 16:30 more_horizontal

On Dynavax's (DVAX) third-quarter earnings call, investors' focus is likely to be on the sales performance of the company's hepatitis B vaccine, HEPLI more_horizontal

Here, we discuss some reasons why investing in Dynavax Technologies (DVAX) stock now may turn out to be a prudent move. more_horizontal

Dynavax Technologies (DVAX) could be a solid choice for shorter-term investors looking to capitalize on the recent price trend in fundamentally sound more_horizontal

The consensus price target hints at a 73.9% upside potential for Dynavax Technologies (DVAX). While empirical research shows that this sought-after me more_horizontal

Dynavax Technologies (DVAX) could be a solid choice for shorter-term investors looking to capitalize on the recent price trend in fundamentally sound more_horizontal

The average of price targets set by Wall Street analysts indicates a potential upside of 70.6% in Dynavax Technologies (DVAX). While the effectiveness more_horizontal

IAS, DVAS and KTOS made it to the Zacks Rank #1 (Strong Buy) momentum stocks list on August 4, 2023. more_horizontal